Skip to content

Comparision of opioid free anaesthesia by using retrolaminar block

“Comparision of opioid free anaesthesia by using bilateral retrolaminar block with conventional opioid based anaesthesia for improved recovery in patients undergoing lumbar laminectomy: A randomised controlled interventional study ? - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076848
Enrollment
60
Registered
2024-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

Intervention1: retrolaminar block: administration of bilateral retrolaMinar block by the operating surgeon directly into the retrolaminar space after skin incision.Administered only once during surger
at intervals for analgesia

Sponsors

Dr Dhamodharan M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Body mass index (BMI): 18–28kg/m2 American Standards Association (ASA) grade I–II; Patients undergoing elective surgeries of lumbar laminectomy

Exclusion criteria

Exclusion criteria: Patient refusal 2) History of allergy to study drugs; 3) Pregnant and lactating females 4) Lower limb weakness with motor or sensory disturbances 4) History of chronic pain or long-term use of psychotropic drug or substance abuse

Design outcomes

Primary

MeasureTime frame
To compare the recovery timeTimepoint: assessed postoperatively at the time of baseline during extubation

Secondary

MeasureTime frame
tracheal extubation timeTimepoint: assessed at the time of baseline;discharge from PACUTimepoint: assessed at the time of 15 mins from baseline;pain score at rest & movement using VASTimepoint: timed intervals at every half an hour from baseline to 24 hours postoperatively;duration of analgesiaTimepoint: assessed every half an hour from the time of baseline;total tramadol consumptionTimepoint: assessed for 24hours of postoperative period from baseline;postoperative side effects such as nausea & vomitingTimepoint: during 24hours of postoperative period from baseline

Countries

India

Contacts

Public ContactDr Gayatri tanwar

Dr S N medical college

fatehbhati68@gmail.com9461028789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026